Scientists identify new target for melanoma immunotherapy
QIMR Berghofer research has found a new reason why some melanoma patients do not respond well to immunotherapy—a discovery that could lead to better-tailored treatments for the potentially deadly cancer.
Jun 30, 2020
0
91